Found: 37
Select item for more details and to access through your institution.
Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial).
- Published in:
- International Journal of Geriatric Psychiatry, 2024, v. 39, n. 6, p. 1, doi. 10.1002/gps.6108
- By:
- Publication type:
- Article
Overcoming Recruitment Challenges and Increasing Representation and Diversity of Participation in Early MCI Clinical Trials: The MIND Study Experience.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083080
- By:
- Publication type:
- Article
Heterogeneity of response to methylphenidate in apathetic patients in the ADMET 2 Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1, doi. 10.1002/alz.066932
- By:
- Publication type:
- Article
Special Circumstances of Persons with Dementia and Agitation in Hospice Care.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1, doi. 10.1002/alz.064698
- By:
- Publication type:
- Article
Leukocyte Surface Biomarkers Implicate Deficits of Innate Immunity in Late‐onset Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065030
- By:
- Publication type:
- Article
An examination of white matter integrity and functional network organization in Subjective Cognitive Decline using Diffusional Kurtosis Imaging‐based tractography resting state fMRI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.066359
- By:
- Publication type:
- Article
Premature aging in co‐occurring Alcohol Use Disorder and Post‐Traumatic Stress Disorder from a functional connectome perspective.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, p. 1, doi. 10.1002/alz.062507
- By:
- Publication type:
- Article
Apathy in Dementia Methylphenidate Trial 2 (ADMET2): Results of a phase III, placebo‐controlled, double‐blind, 6‐month, multi‐center, randomized clinical trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051489
- By:
- Publication type:
- Article
Alcohol use disorder and mild cognitive impairment: Shared neural signatures during an episodic memory task.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.058535
- By:
- Publication type:
- Article
P4‐280: BRAIN AMYLOID BURDEN, SLEEP, AND CIRCADIAN REST/ACTIVITY RHYTHMS: SCREENING FINDINGS FROM A4 AND LEARN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1554, doi. 10.1016/j.jalz.2018.07.102
- By:
- Publication type:
- Article
Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer’s Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2018, v. 33, n. 7, p. 450, doi. 10.1177/1533317518783278
- By:
- Publication type:
- Article
MEASURING APATHY IN ALZHEIMER'S DISEASE IN THE APATHY IN DEMENTIA METHYLPHENIDATE TRIAL 2 (ADMET 2): A COMPARISON OF INSTRUMENTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P184, doi. 10.1016/j.jalz.2017.07.038
- By:
- Publication type:
- Article
PREDICTION OF RELAPSE FOLLOWING DISCONTINUATION OF ANTIPSYCHOTIC TREATMENT IN ALZHEIMER'S DISEASE: THE ROLE OF HALLUCINATIONS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P208, doi. 10.1016/j.jalz.2016.06.365
- By:
- Publication type:
- Article
Dextromethorphan/quinidine (AVP-923) for treatment of agitation in patients with Alzheimer’s disease: Analysis of week 10 results for patients treated only with AVP-923 versus patients receiving only placebo (NCT01584440).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P291, doi. 10.1016/j.jalz.2015.07.397
- By:
- Publication type:
- Article
Dextromethorphan/quinidine (AVP-923) phase 2 study for treatment of agitation in Alzheimer’s disease: Comparing the enrolled agitation sample with the international psychogeriatric association definition of agitation in cognitive disorders (NCT01584440)
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P751, doi. 10.1016/j.jalz.2015.06.1675
- By:
- Publication type:
- Article
Effects of citalopram on neuropsychiatric symptoms in Alzheimer’s dementia: Evidence from the citad study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P526, doi. 10.1016/j.jalz.2015.06.650
- By:
- Publication type:
- Article
Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 1, p. 36, doi. 10.1016/j.jalz.2013.01.014
- By:
- Publication type:
- Article
Citalopram for agitation in Alzheimer’s disease: Design and methods
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2012, v. 8, n. 2, p. 121, doi. 10.1016/j.jalz.2011.01.007
- By:
- Publication type:
- Article
P3-439: The international psychogeriatric association and Alzheimer's disease international assessment of Alzheimer's care in Europe and the far east
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P2-412: MPC-7869 (R-flurbiprofen), a selective Aβ42-lowering agent, delays time to clinically significant psychiatric events in Alzheimer’s disease (AD): Analysis from a 12-month phase 2 trial
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P2-412: MPC-7869 (R-flurbiprofen), a selective Aβ42-lowering agent, delays time to clinically significant psychiatric events in Alzheimer’s disease (AD): Analysis from a 12-month phase 2 trial
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0098426
- By:
- Publication type:
- Article
Establishment of a Predominantly African-American Cohort for the Study of Alzheimer’s Disease.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2009, v. 27, n. 4, p. 329, doi. 10.1159/000207446
- By:
- Publication type:
- Article
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 3, p. 784, doi. 10.1111/bcp.12997
- By:
- Publication type:
- Article
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparison of Rapidly Acting Intramuscular Olanzapine, Lorazepam, and Placebo: A Double-blind, Randomized Study in Acutely Agitated Patients with Dementia
- Published in:
- Neuropsychopharmacology, 2002, v. 26, n. 4, p. 494, doi. 10.1016/S0893-133X(01)00365-7
- By:
- Publication type:
- Article
Behavioral Intensive Care Unit (BICU): A new concept in the management of acute agitated behavior...
- Published in:
- Gerontologist, 1993, v. 33, n. 6, p. 801, doi. 10.1093/geront/33.6.801
- By:
- Publication type:
- Article
A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2427073, doi. 10.1001/jamanetworkopen.2024.27073
- By:
- Publication type:
- Article
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of Citalopram on Agitation in Alzheimer Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 7, p. 682, doi. 10.1001/jama.2014.93
- By:
- Publication type:
- Article
Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 1, p. 33, doi. 10.1001/jama.2013.282834
- By:
- Publication type:
- Article
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
- Published in:
- 2011
- By:
- Publication type:
- journal article
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
- Published in:
- International Journal of Geriatric Psychiatry, 2011, v. 26, n. 6, p. 573, doi. 10.1002/gps.2565
- By:
- Publication type:
- Article
Clinical application of operationalized criteria for ‘Depression of Alzheimer's Disease’.
- Published in:
- International Journal of Geriatric Psychiatry, 2005, v. 20, n. 2, p. 119, doi. 10.1002/gps.1261
- By:
- Publication type:
- Article
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
- Published in:
- International Journal of Geriatric Psychiatry, 2004, v. 19, n. 1, p. 9, doi. 10.1002/gps.998
- By:
- Publication type:
- Article